Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Automated And Closed Cell Therapy Processing Systems Market, by workflow
1.4.2 Europe Automated And Closed Cell Therapy Processing Systems Market, by type
1.4.3 Europe Automated And Closed Cell Therapy Processing Systems Market, by Scale
1.4.4 Europe Automated And Closed Cell Therapy Processing Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2018, Feb – 2021, Oct) Leading Players
Chapter 4. Europe Automated and Closed Cell Therapy Processing Systems Market by Type
4.1 Europe Non-Stem Cell Therapy Market by Country
4.2 Europe Stem Cell Therapy Market by Country
Chapter 5. Europe Automated and Closed Cell Therapy Processing Systems Market by Workflow
5.1 Europe Expansion Market by Country
5.2 Europe Separation Market by Country
5.3 Europe Apheresis Market by Country
5.4 Europe Cryopreservation Market by Country
5.5 Europe Fill- Finish Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Automated and Closed Cell Therapy Processing Systems Market by Scale
6.1 Europe Pre-commercial/ R&D Scale Market by Country
6.2 Europe Commercial Scale Market by Country
Chapter 7. Europe Automated and Closed Cell Therapy Processing Systems Market by Country
7.1 Germany Automated and Closed Cell Therapy Processing Systems Market
7.1.1 Germany Automated and Closed Cell Therapy Processing Systems Market by Type
7.1.2 Germany Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.1.3 Germany Automated and Closed Cell Therapy Processing Systems Market by Scale
7.2 UK Automated and Closed Cell Therapy Processing Systems Market
7.2.1 UK Automated and Closed Cell Therapy Processing Systems Market by Type
7.2.2 UK Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.2.3 UK Automated and Closed Cell Therapy Processing Systems Market by Scale
7.3 France Automated and Closed Cell Therapy Processing Systems Market
7.3.1 France Automated and Closed Cell Therapy Processing Systems Market by Type
7.3.2 France Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.3.3 France Automated and Closed Cell Therapy Processing Systems Market by Scale
7.3.4 Russia Automated and Closed Cell Therapy Processing Systems Market
7.3.5 Russia Automated and Closed Cell Therapy Processing Systems Market by Type
7.3.6 Russia Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.3.7 Russia Automated and Closed Cell Therapy Processing Systems Market by Scale
7.4 Spain Automated and Closed Cell Therapy Processing Systems Market
7.4.1 Spain Automated and Closed Cell Therapy Processing Systems Market by Type
7.4.2 Spain Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.4.3 Spain Automated and Closed Cell Therapy Processing Systems Market by Scale
7.5 Italy Automated and Closed Cell Therapy Processing Systems Market
7.5.1 Italy Automated and Closed Cell Therapy Processing Systems Market by Type
7.5.2 Italy Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.5.3 Italy Automated and Closed Cell Therapy Processing Systems Market by Scale
7.6 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market
7.6.1 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market by Type
7.6.2 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.6.3 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market by Scale
Chapter 8. Company Profiles
8.1 Lonza Group AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Terumo Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Product Launches and Product Expansions:
8.3 Cytiva (Danaher Corporation)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Miltenyi Biotech B.V. & Co. KG
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.5.2.2 Product Launches and Product Expansions:
8.5.2.3 Acquisition and Mergers:
8.6 ThermoGenesis Holdings, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.7 Cellares, Inc.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Biospherix ltd.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 Sartorius AG
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Product Launches and Product Expansions:
8.1 Fresenius SE & Co. KGaA
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Acquisition and Mergers:
Unique Offerings 